Biotek-snakken — August 2024
-
Godmorgen

-
Madrigal's MASH drug Rezdiffra blows past estimates in Q2 https://firstwordpharma.com/story/5883184
-
Ascelia Pharma Announces Final Terms of Rights Issue
Ascelia Pharma Announces Final Terms of Rights Issue – ASCELIA
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, ...
(www.ascelia.com)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind